Lentiviral-mediated integrin α5 expression in human adult mesenchymal stromal cells promotes bone repair in mouse cranial and long-bone defects.
暂无分享,去创建一个
R. Müller | O. Fromigué | P. Marie | P. Vaudin | G. Kuhn | E. Livne | S. Srouji | D. Ben-David
[1] Ralph Müller,et al. A model for tissue engineering applications: femoral critical size defect in immunodeficient mice. , 2011, Tissue engineering. Part C, Methods.
[2] A. Augello,et al. The Regulation of Differentiation in Mesenchymal Stem Cells , 2010 .
[3] P. Bianco,et al. "Mesenchymal" stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease. , 2010, Human gene therapy.
[4] C. De Bari,et al. The regulation of differentiation in mesenchymal stem cells. , 2010, Human gene therapy.
[5] C. Evans. Gene therapy for bone healing , 2010, Expert Reviews in Molecular Medicine.
[6] Jochen Ringe,et al. Crosstalks between integrin alpha 5 and IGF2/IGFBP2 signalling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiation , 2010, BMC Cell Biology.
[7] J. Ringe,et al. Priming integrin alpha5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis , 2009 .
[8] D. Prockop. Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[9] R. Schüle,et al. FHL2 mediates dexamethasone‐induced mesenchymal cell differentiation into osteoblasts by activating Wnt/β‐catenin signaling‐dependent Runx2 expression , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] K. Shakesheff,et al. Gene therapy used for tissue engineering applications , 2007, The Journal of pharmacy and pharmacology.
[11] O. Fromigué,et al. Osteogenic differentiation of human marrow-derived mesenchymal stem cells. , 2006, Regenerative medicine.
[12] P. Rosset,et al. Mesenchymal stem cells in bone and cartilage repair: current status. , 2006, Regenerative medicine.
[13] M. Liebergall,et al. Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration. , 2006, Tissue engineering.
[14] R. Franceschi,et al. Biological Approaches to Bone Regeneration by Gene Therapy , 2005, Journal of dental research.
[15] P. Marie,et al. Cbl-mediated ubiquitination of α5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation , 2005, Journal of Cell Science.
[16] Marc Hedrick,et al. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. , 2005, Tissue engineering.
[17] M. Kassem. Mesenchymal stem cells: biological characteristics and potential clinical applications. , 2004, Cloning and stem cells.
[18] G. Stein,et al. Runx2/Cbfa1: a multifunctional regulator of bone formation. , 2003, Current pharmaceutical design.
[19] D. Prockop,et al. One strategy for cell and gene therapy: Harnessing the power of adult stem cells to repair tissues , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] Ralph Müller,et al. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices , 2003, Nature Biotechnology.
[21] R. Müller,et al. Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy , 2001, The journal of gene medicine.
[22] A. Meunier,et al. Tissue-engineered bone regeneration , 2000, Nature Biotechnology.
[23] P. Bianco,et al. Marrow stromal stem cells. , 2000, The Journal of clinical investigation.
[24] B. Frenkel,et al. Osteoblast-specific gene expression after transplantation of marrow cells: implications for skeletal gene therapy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[25] D. Gazit,et al. Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell‐mediated gene therapy , 1999, The journal of gene medicine.
[26] T A Einhorn,et al. The cell and molecular biology of fracture healing. , 1998, Clinical orthopaedics and related research.
[27] F. Giancotti,et al. Elevated levels of the α 5 β 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells , 1990, Cell.
[28] P. Charbord,et al. Culture and characterization of human bone marrow mesenchymal stem cells. , 2007, Methods in molecular medicine.
[29] C. Dufour,et al. Skeletal unloading induces osteoblast apoptosis and targets alpha5beta1-PI3K-Bcl-2 signaling in rat bone. , 2007, Experimental cell research.
[30] Mark Clements,et al. Mesenchymal stem cells , 2007, Stem Cell Reviews.
[31] P. Rüegsegger,et al. A microtomographic system for the nondestructive evaluation of bone architecture , 2006, Calcified Tissue International.
[32] Ralph Müller,et al. Trabecular bone failure at the microstructural level , 2006, Current osteoporosis reports.
[33] E. Ruoslahti,et al. Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. , 1990, Cell.